A Cross-Sectoral Comparison of Prevalence and Predictors of Symptoms of Depression Over Time Among Older Adults in Ontario, Canada.

Journal of Geriatric Psychiatry and Neurology
Eva NeufeldUrszula Horwath

Abstract

Late-life depression, a common mental health issue, poses a significant burden of illness globally. We investigated factors associated with symptoms of depression among older adults across 3 health sectors in Ontario, Canada. Electronic health assessment data on older adults aged 60 years+ in home care (HC; N = 359 217), long-term care (LTC; N = 125 496), and palliative care (PC; N = 29 934) were examined. Change in symptoms of depression, measured using the interRAI Depression Rating Scale (DRS), over time was examined, including predictors of the development of depression. At baseline, symptoms of depression were observed in 19.1% (HC), 24.2% (LTC), and 11.9% (PC). This increased to 20.6% (HC), 33.8% (LTC), and 13.2% (PC) at follow-up. For most older adults, DRS scores remained the same across sectors over time. Three independent variables emerged consistently across sectors as the main risk and protective factors for symptoms of depression. Although variations in the risk and protective factors for late-life depression were demonstrated across each sector, some commonalities emerged including unmanaged pain, symptoms of depression at baseline, social connectedness, and activity.

References

Jul 1, 1994·Journal of Gerontology·J N MorrisL A Lipsitz
Feb 24, 2001·Medical Care·F LandiUNKNOWN SILVERNET-HC Study Group of Bergamo
May 1, 2001·The Gerontologist·B E FriesF L Bookstein
Oct 30, 2001·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·F StiefelA Razavi
Jun 8, 2002·BMJ : British Medical Journal·Margda WaernP Allebeck
Oct 4, 2002·Biological Psychiatry·George S AlexopoulosK Ranga R Krishnan
May 27, 2004·Journal of the American Geriatrics Society·Ellen L BrownPamela Nassisi
Jun 7, 2005·Lancet·George S Alexopoulos
May 12, 2006·Journal of the American Geriatrics Society·Yael Harris, James K Cooper
Sep 1, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Jennifer L RoweMartha L Bruce
Jan 26, 2007·Pain·Jolanta ZyczkowskaJohn P Hirdes
May 3, 2007·Journal of Palliative Medicine·Nazneen Hyder Noorani, Marcos Montagnini
Jun 5, 2007·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Kaarin J AnsteyMary A Luszcz
Mar 13, 2008·Journal of Palliative Medicine·Scott A IrwinFrank D Ferris
Sep 26, 2008·Healthcare Management Forum·J W PossK Reidel
Oct 7, 2009·International Journal of Geriatric Psychiatry·Menke BallerHein P J van Hout
Apr 21, 2010·Archives of Gerontology and Geriatrics·Tal Bergman LevyDov Aizenberg
Jun 5, 2010·International Psychogeriatrics·Dallas SeitzDavid Conn
Nov 13, 2010·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Kendra JonesTracey Scott
May 3, 2011·Psychiatric Services : a Journal of the American Psychiatric Association·Huibo ShaoYuhua Bao
Sep 29, 2011·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Katarzyna SzczerbińskaJolanta Zyczkowska
Nov 23, 2011·Palliative & Supportive Care·Patricia AustinLeigh Archer
Apr 11, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Andrea Iaboni, Alastair J Flint
Oct 12, 2014·The American Journal of Hospice & Palliative Care·Cecilia Håkanson, Joakim Öhlén

❮ Previous
Next ❯

Methods Mentioned

BETA
MDS

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.